Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Builds on 2021 Growth with Plans for 86 Plant-based Store Outlets, Ongoing Educational Efforts in Coming Year

Plant-based lifestyle brand builder PlantX Life Inc. offers more than 5,000 plant-based products through meal and indoor plant deliveries, and the company is working through research and development to introduce new product categories in the coming year PlantX is also adding to its physical XMarket store locations, advancing from initial British Columbia and California outlets […]

FingerMotion Inc. (NASDAQ: FNGR) Q3 Financial Report Notes Record Profit Growth, Ongoing Efforts to Build SMS, Big Data Services

U.S.-based communications technology brand FingerMotion is building its profits as it focuses on services for China’s world-leading, mobile-connected population FingerMotion recently reported its financial statement for the Q3 quarter ending Nov. 30, noting gross profits at a record $967,075 The profits report was 56 percent higher than the same period during the previous year, driven […]

Nowigence Inc. (NOWG) Offers PKM Solution with Proprietary Pluaris Platform

Personal knowledge management involves creating systems, adding context and making information easy to surface when needed The customizable, user-friendly Pluaris platform assists users with reading and analyzing textual data and so much more Nowigence is focused on simplifying the challenges of learning The idea of personal knowledge management (“PKM”) systems is gaining traction, with a growing […]

Nemaura Medical Inc. (NASDAQ: NMRD) Firmly Positioned in Growing Diabetes Tech Market With Recent CGM Shipment to UK Licensee

Diabetes tech market expanded in 2021 due to new users, growing demand for CGM devices, coverage of CGM devices by CMS Diabetes is a growing problem in the US. According to CDC, roughly 1 in 10 Americans have diabetes, and 1 in 3 have pre-diabetes NMRD currently commercializing the sugarBEAT(R) non-invasive and flexible continuous glucose […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Marks Great Start to its 2022 R&D Programs Following Independent Review Board Approval

Lexaria received independent review board approval for its HYPER-H21-4 human clinical study for hypertension treatment The stage is also set for other R&D programs for the 2022 calendar year, including HOR-A22-1, DEM-A22-1, RHEUM-A22-1 and DIAB-A22-1 All of these 2022 R&D programs are fully funded, with Lexaria having raised approximately $15 million over the 2021 calendar […]

SRAX Inc. (NASDAQ: SRAX) Appears to Be on a Hot Streak; Announced Revenue Guidance for 2022 Expecting Another Period of Outstanding Performance

SRAX’s performance goes from strength to strength; company announced revenue guidance expecting revenues of $11.5 million for the first quarter and full-year revenues of $46M – $48M. Company’s SaaS platform Sequire expected to continue to drive growth and remain instrumental to performance. As go-to data provider for investors and public companies, SRAX stays committed to […]

InnerScope Hearing Technologies Inc. (INND) Seeks to Address Shortfalls in United States Hearing Aid Market; CEO Matthew Moore Presented at the Emerging Growth Conference

Over 466 million people current suffer from disabling hearing loss with a further 1.1 billion people at risk of suffering hearing damage Elevated device cost, poor after-sales service, and a lack of access to proper healthcare have led to only 14% of the 48 million American with hearing loss to currently use hearing aid devices […]

Attend DGE’s 2nd Next-Gen MSL Excellence Summit

MSLs are critical in ensuring that products are used efficiently throughout their lifecycle. They serve as scientific peers and resources within the medical community, and provide valuable expertise to internal colleagues. MSLs, like the rest of the life science industry, must quickly adapt to the introduction of new technological platforms and rethink their workload in […]

 

From Our Blog

Quantum BioPharma Ltd. (NASDAQ: QNTM) Pursues a New Path for Better Multiple Sclerosis Treatments

September 22, 2026

Nearly three million people around the world wake up every day managing a disease that has no cure, and the number keeps climbing. That reality is what makes new approaches to multiple sclerosis worth paying attention to, and it is the space where Quantum BioPharma (NASDAQ: QNTM) is working to make a difference with its […]

Rotate your device 90° to view site.